AXGN
AXGN
NASDAQ · Health Care

Axogen Inc

$33.33
+0.72 (+2.21%)
As of Mar 25, 1:40 PM ET ·
Financial Highlights (FY 2026)
Revenue
254.92M
Net Income
-17,774,592
Gross Margin
74.3%
Profit Margin
-7.0%
Rev Growth
+17.6%
D/E Ratio
0.38
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.3% 74.3% 49.7% 49.7%
Operating Margin -3.5% -3.1% 10.8% 8.6%
Profit Margin -7.0% -6.6% 8.2% 9.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 254.92M 216.84M 948.34M 1.09B
Gross Profit 189.43M 161.13M 471.45M 543.24M
Operating Income -8,896,597 -6,810,936 102.11M 94.06M
Net Income -17,774,592 -13,607,632 77.32M 101.42M
Gross Margin 74.3% 74.3% 49.7% 49.7%
Operating Margin -3.5% -3.1% 10.8% 8.6%
Profit Margin -7.0% -6.6% 8.2% 9.3%
Rev Growth +17.6% +17.6% +5.7% +24.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 203.29M 203.29M 208.98M 163.48M
Total Equity 540.80M 540.80M 1.19B 1.27B
D/E Ratio 0.38 0.38 0.18 0.13
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -1,157,172 -935,108 143.45M 157.61M
Free Cash Flow 51.25M 59.12M